Table 2. Functional properties of clobazam, N-desmethylclobazam, and clonazepam at the human α1β2γ2S, α2β2γ2S, α3β2γ2S, α5β2γ2S, α6β2δ and α6β2GABAARs expressed in Xenopus oocytes.
Receptor | EC50 [pEC50 ± S.E.M.] | Imax ± S.E.M. (%) | N |
---|---|---|---|
Clobazam | |||
α1β2γ2S | 132 [6.88 ± 0.05] | 256 ± 12 | 5 |
α2β2γ2S | 138 [6.86 ± 0.04] | 261 ± 6.7 | 6 |
α3β2γ2S | 240 [6.62 ± 0.10] | 269 ± 0.8 | 4 |
α5β2γ2S | 174 [6.76 ± 0.03] | 216 ± 7.0 | 6 |
α6β2δ | 55,000 [4.26 ± 0.04] | 528 ± 46 | 6 |
N-desmethylclobazam | |||
α1β2γ2S | 151 [6.82 ± 0.07] | 203 ± 8.5 | 6 |
α2β2γ2S | 138 [6.86 ± 0.18] | 270 ± 20 | 6 |
α3β2γ2S | 282 [6.55 ± 0.11] | 270 ± 27 | 5 |
α5β2γ2S | 98 (123 and 79) b | 233 (248 and 217) b | 2 |
α6β2δ | ∼300,000 [∼3.5] a | 2420 ± 210 a | 5 |
α6β2 | ∼300,000 [∼3.5] a | 2350 ± 200 a | 4 |
Clonazepam | |||
α1β2γ2S | 15 [7.81 ± 0.12] | 209 ± 14 | 4 |
α2β2γ2S | 7.4 [8.13 ± 0.04] | 253 ± 17 | 5 |
α3β2γ2S | 16 (20 and 13) b | 316 (334 and 297) b | 2 |
α5β2γ2S | 21 [7.68 ± 0.17] | 255 ± 25 | 5 |
α6β2δ | 29,000 [4.53 ± 0.10] | 283 ± 38 | 5 |
a The concentration-response curves for N-desmethylclobazam at the α6β2δ and α6β2GABAARs were not saturated at the maximal concentration used (1 mM). Thus, for this receptors the EC50 and pEC50 values for N-desmethylclobazam are estimated from the data, and the currents evoked by 1 mM N-desmethylclobazam (in % of the GABA EC20 response) is given instead of Imax.
b The properties for N-desmethylclobazam at α5β2γ2S and for clonazepam at α3β2γ2S are based on two independent experiments (n = 2), and thus the mean EC50 and Imax values for the modulators are given with specific EC50 and Imax values determined in the two experiments in parantheses.